Octave Biosciences Takes It Up Another Semitone With Michael J Fox Foundation Grant

The diagnostics company has secured $10m from the foundation to develop a biomarker test for Parkinson’s disease.

• Source: Shutter

Patients suspected of having Parkinson’s disease are often forced to embark on a long and uncertain diagnostic journey. 

First comes an appointment with a primary care physician – this will usually assess any problems with the patient’s motility and check for any tremor, the symptoms most associated with...

More from Diagnostics

More from Device Area